Abdominal Transplant Fellowship »  Faculty »  Hepatology »  Danielle Brandman, M.D., M.A.S.
Danielle Brandman, M.D., M.A.S.

Danielle Brandman, M.D., M.A.S.

Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 514-1094 - Phone
(415) 476-0659 - Fax
Danielle.Brandman@ucsf.edu
Open Popup
  • Boston University, B.A., Biology and Psychology, 1995-1999
  • UMDNJ-New Jersey Medical School, M.D., 2001-2005
  • University of California, San Francisco, M.A.S., Clinical Research, 2009-2011
  • University of California, San Francisco, Intern, Medicine, 2005-2006
  • University of California, San Francisco, Resident, Medicine, 2006-2008
  • University of California, San Francisco, Fellow, Gastroenterology, 2008-2011
  • University of California, San Francisco, Fellow, Transplant Hepatology, 2011-2012
  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology
  • UCSF Liver Center
  • Acute Liver Failure (ALF)
  • Alcoholic Liver Disease
  • Autoimmune Hepatitis
  • Choledochal Cysts
  • Cirrhosis
  • Hemochromatosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Primary Liver Cancer)
  • Liver Transplantation
  • Living Donor Liver Transplantation
  • Non-alcoholic Fatty Liver Disease
  • Polycystic Liver Disease
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Toxic Hepatitis
  • Hepatitis C virus (HCV)
  • Liver injury and repair (Liver transplantation)
  • Nonalcoholic steatohepatitis (NASH)

Dr. Danielle Brandman is an Assistant Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include nonalcoholic fatty liver disease and post-transplant metabolic syndrome.  She engages in outcomes-based research with a special interest in NAFLD and liver transplantation: the post-transplant outcomes of patients with NAFLD, selection of patients with NAFLD for transplant, recurrence of NAFLD following transplant, and new-onset NAFLD after liver transplantation for other causes of liver disease

Dr. Brandman received her medical degree at UMDNJ New Jersey Medical School in 2005. She continued her medical training at University of California, San Francisco, where she completed her residency, gastroenterology fellowship, transplant hepatology fellowship, and master's degree in clinical research. Dr. Brandman is certified by the American Board of Internal Medicine in internal medicine and gastroenterology.  She is a member of the American Association for the Study of Liver Disease (AASLD).

  1. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N. Performance Characteristics of Vibration-Controlled Transient Elastography for Evaluation of Non-Alcoholic Fatty Liver Disease. Hepatology. 2017 Aug 31. View in PubMed
  2. Kardashian AA, Dodge JL, Roberts J, Brandman D. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. Liver Int. 2017 Jul 20. View in PubMed
  3. Brandman D. Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? Aliment Pharmacol Ther. 2017 May; 45(9):1272-1273. View in PubMed
  4. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver Transplant (LT) recipients with Nonalcoholic Steatohepatitis (NASH) Have Lower Risk Hepatocellular Carcinoma (HCC). Liver Transpl. 2017 Mar 24. View in PubMed
  5. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. View in PubMed
  6. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl. 2011 Dec; 17(12):1380-6. View in PubMed
  7. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64. View in PubMed
  8. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 2002 Aug 5; 111(1):11-20. View in PubMed
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Danielle Brandman, M.D., M.A.S.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X